Abstract:Background: The lifespan of Marfan Syndrome (MFS) patients is shortened, especially in patients without early diagnostics, preventive treatment, and elective surgery. Clinically, MFS diagnosis is mainly dependent on phenotypes, but for children, sporadic cases, or suspicious MFS patients, molecular genetic testing, and mainly FBN1 mutation screening, plays a significant role in the diagnosis of MFS. PGT-M gives couples that had a family history of monogenic disorders the opportunity to avoid the occurrence of MFS. Methods: In this study, 11 families with MFS were recruited and complete clinical features were collected. Variants were classified and interpreted through pedigree analysis according to guidelines. Two families chose to undergo PGT-M; 16 blastocysts were biopsied and amplified. Haplotype analysis was performed to deduce the embryo’s genotype by using single nucleotide polymorphisms (SNPs) identified in each sample. Results: We identified 11 potential disease-causing FBN1 variants, six of which are novel. All variants were assessed with prediction tools to assess mutation pathogenicity, population databases to evaluate population allele frequency, literature databases to identify whether the variant had been reported in MFS patients, and multiple sequence alignment to carry out conservative analysis. Finally, nine variants were classified as likely pathogenic/pathogenic variants. Among 11 variants, eight variants were missense, and seven of them were located in the Ca-binding EGF-like motifs, moreover, half of them substituted conserved Cysteine residues. We also identified a splice site variant, a frameshift variant, and a synonymous variant. There are two variants that are de novo variants. PGT-M helped two MFS families give birth to a healthy baby not carrying the FBN1 mutation. Conclusions: In the present study, the FBN1 mutation spectrum was enriched, and may help further elucidate the pathogenesis, benefiting clinical diagnosis and management of MFS. We make use of a reliable PGT-M method for the successful birth of healthy babies to two MFS families.

PGT-M for Premature Ovarian Failure Related to CGG Repeat Expansion of the FMR1 Gene

Genetic Screening in Patients with Ovarian Dysfunction

An Update on Primary Ovarian Insufficiency

Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation

Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations

Association Between Premature Ovarian Failure, Polymorphisms in MTHFR and MTRR Genes and Serum Homocysteine Concentration

A Novel PPRC1 Point Mutation in a Chinese Family with Premature Ovarian Failure: A Case Study

Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model

Analysis of CGG Repeats in FMR1 in Chinese Women with Idiopathic Premature Ovarian Failure

Prevalence of the FMR1 Gene Premutation in Young Women with a Diminished Ovarian Reserve Included in an IVF Program: Implications for Clinical Practice

Outcomes and the effect of PGT-M in women with hormone-related hereditary tumor syndrome

Evidence for an FMR1 mRNA Gain-Of-Function Toxicity Mechanism in the Pathogenesis of Fragile-X Associated Premature Ovarian Insufficiency

A Preliminary Study on the Mechanism of Premature Ovarian Failure

Primary ovarian insufficiency: update on clinical and genetic findings

Genetics of ovarian insufficiency and defects of folliculogenesis

Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain‐of‐function toxicity mechanism contributing to the pathogenesis of fragile X‐associated premature ovarian insufficiency

Identification and Characterization of Novel Compound Heterozygous Variants in FSHR Causing Primary Ovarian Insufficiency with Resistant Ovary Syndrome.

Genetic insights into the complexity of premature ovarian insufficiency

Preimplantation genetic diagnosis for fragile X syndrome: is there increased transmission of abnormal FMR1 alleles among female heterozygotes?

The 'normal' Range of FMR1 Triple CGG Repeats May Be Associated with Primary Ovarian Insufficiency in China.

Cytosine-guanine-guanine Repeats of FMR1 Gene Negatively Affect Ovarian Reserve and Response in Chinese Women